Sign Up to like & get
recommendations!
0
Published in 2017 at "Brazilian Journal of Microbiology"
DOI: 10.1016/j.bjm.2016.12.003
Abstract: Introduction Tuberculosis, particularly multi-drug-resistant tuberculosis, is a major cause of morbidity and mortality worldwide. To the best of our knowledge, however, no study to date has assessed the combined use of the four available drugs…
read more here.
Keywords:
dose combination;
four drug;
treatment;
drug ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International health"
DOI: 10.1093/inthealth/ihad023
Abstract: BACKGROUND Patients with TB resistant to rifampicin (Rr-TB), and those with additional resistance to fluoroquinolones (pre-XDR-TB), should be treated with bedaquiline-pretomanid-linezolid-moxifloxacin and bedaquiline-pretomanid-linezolid, respectively. However, pretomanid is not yet widely available. METHODS This is a…
read more here.
Keywords:
drug standardized;
bedaquiline;
pre xdr;
highly resistant ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.01573
Abstract: [This corrects the article DOI: 10.3389/fonc.2020.01145.].
read more here.
Keywords:
four drug;
therapy nsclc;
erratum neoadjuvant;
neoadjuvant four ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15040403
Abstract: The optimal therapeutic approach for primary HIV infection (PHI) is still debated. We aimed to compare the viroimmunological response to a four- versus a three-drug regimen, both INSTI-based, in patients with PHI. This was a…
read more here.
Keywords:
primary hiv;
drug;
hiv infection;
three drug ... See more keywords